Dr. Kathy Miller previews SABCS 2013, highlighting studies on platinum agents in triple-negative breast cancer, trends in local therapy, and whether CTC levels should guide therapy decisions.
Dr. Kathy Miller previews SABCS 2013, highlighting studies on platinum agents in triple-negative breast cancer, trends in local therapy, and whether CTC levels should guide therapy decisions.